Commercial-Scale Recombinant Proteins CDMOs

← All Recombinant Proteins CDMOs Best Clean FDA History Commercial Scale

CDMOs tracked

Fully scored

With FDA records

FDA inspections

EMA/MHRA GMP certs

Warning letters

Recombinant protein CDMOs make therapeutic proteins, enzymes, and growth factors using microbial (E. coli, yeast) or mammalian (CHO) expression. Choice of host turns on post-translational modification needs, scale economics, and downstream-purification complexity.

Selecting a recombinant protein CDMO turns on host-system experience, validated bioreactor scale, downstream purification and analytics, and a clean regulatory record. The rankings below score each CDMO on FDA inspections, GMP certification, clinical activity, and capacity.

FDA inspection outcomes across these CDMOs: 3 NAI (no action), 9 VAI (voluntary action), 1 OAI (official action). Leading inspection & GMP sites: Germany (25), United States (12), Lithuania (8), UNITED KINGDOM (8), UNITED STATES (8).

Last updated 2026-06-29. Sourced from FDA, EMA EudraGMDP, MHRA GMDP, and ClinicalTrials.gov.

#	CDMO	Signal Score	Quality	FDA · GMP	Capacity	Programs
1	KB KBI Biopharma Durham, NC · Boulder, CO	83.5	100.0	1 insp · 1 GMP	Limited	0 programs
2	RB Richter BioLogics Hamburg, Germany	82.9	100.0	0 insp · 9 GMP	—	0 programs
3	WK Wacker Biotech Jena, DE · Amsterdam, NL · San Diego, CA	81.6	100.0	0 insp · 13 GMP	—	0 programs
4	NW Northway Biotech Vilnius, LT; Waltham (MA), USA	80.8	100.0	0 insp · 8 GMP	Available	0 programs
5	RB Rentschler Biopharma Laupheim, Germany	79.9	99.3	1 insp · 2 GMP	—	0 programs
6	Catalent Somerset, NJ (now operating under Novo Holdings, HQ effectively Bagsværd, Denmark)	76.5	79.3	10 insp · 32 GMP	—	0 programs
7	CA Catalent (Novo Holdings) Harmans, MD · Gosselies, BE	75.1	79.3	1 insp · 0 GMP	Available	0 programs

How we score CDMOs →

What to evaluate in a Recombinant Proteins CDMO

Expression host & scale

Microbial hosts (E. coli, P. pastoris) suit non-glycosylated proteins; mammalian (CHO) is the workhorse for glycoproteins. Confirm validated bioreactor scale and the CDMO's experience with your target.

Purification & analytics

Downstream complexity (multiple chromatography steps, refolding for E. coli) drives cost and timeline. Ask about the orthogonal analytics package — purity, identity, potency.

Regulatory readiness

Clean FDA 483 history and EMA/MHRA GMP coverage matter — both are shown above and on each profile.

Capacity & commercial readiness

For programs heading to BLA, evaluate validated commercial scale and any approved-product track record.

Recombinant Proteins CDMOs — Frequently Asked Questions

Who are the top Recombinant Proteins CDMOs?

By CDMO Signal's independent Signal Score, the top-ranked Recombinant Proteins CDMOs include KBI Biopharma, Richter BioLogics, Wacker Biotech. See the full ranked table above — scored on FDA, clinical, financial, and capacity data.

How many Recombinant Proteins CDMOs have FDA inspection records?

CDMO Signal tracks 4 Recombinant Proteins CDMOs with FDA inspection records and 65 EMA/MHRA GMP certificates across the group.

What should I look for in a recombinant protein CDMO?

Confirm expression-host experience for your target (microbial vs mammalian), validated bioreactor scale, a strong downstream-purification platform, qualified analytics, and a clean FDA and EMA/MHRA record.

How is a recombinant protein CDMO different from a mAb CDMO?

There's significant overlap — mAbs are recombinant proteins. But mAb CDMOs are typically optimized for CHO-based platform processes, while general recombinant protein CDMOs handle a wider range of hosts and non-mAb formats (enzymes, growth factors, complex non-glycoproteins).

Related modalities

Biologics / mAb CDMOs mRNA / LNP CDMOs Cell Therapy CDMOs

Other Modalities

AAV CAR-T Lentiviral Cell Therapy mRNA/LNP Plasmid DNA Biologics Oligo/ASO Adenoviral Gene Editing Exosome ADC